1,8-Diazabicyclo(5.4.0)undec-7-ene → 2-(7-Chloro-1,8-naphthyridin-2-yl)-3-oxo-1-isoindolinyl 3-diisopropylaminopropionate
反応式
Cl[CH:2]1[C:10]2[C:5](=[CH:6][CH:7]=[CH:8][CH:9]=2)[C:4](=[O:11])[N:3]1[C:12]1[CH:21]=[CH:20][C:19]2[C:14](=[N:15][C:16]([Cl:22])=[CH:17][CH:18]=2)[N:13]=1.Cl.[CH:24]([N:27]([CH:33]([CH3:35])[CH3:34])[CH2:28][CH2:29][C:30]([OH:32])=[O:31])([CH3:26])[CH3:25].N12CCCN=C1CCCCC2>CN(C)C=O>[CH:33]([N:27]([CH:24]([CH3:26])[CH3:25])[CH2:28][CH2:29][C:30]([O:32][CH:2]1[C:10]2[C:5](=[CH:6][CH:7]=[CH:8][CH:9]=2)[C:4](=[O:11])[N:3]1[C:12]1[CH:21]=[CH:20][C:19]2[C:14](=[N:15][C:16]([Cl:22])=[CH:17][CH:18]=2)[N:13]=1)=[O:31])([CH3:35])[CH3:34]参加物
5
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
Working as in Example 1, but starting with 3-chloro-2-(7-chloro-1,8-naphthyridin-2-yl)-1-isoindolinone (6.9 g) in anhydrous dimethylformamide (70 cc), 3-diisopropylaminopropionic acid hydrochloride (4.4 g) and 1,8-diazabicyclo-[5.4.0]undec-7-ene (7.45 g), and after the residue obtained has been recrystallized successively, first in acetonitrile and then in ethanol, 2-(7-chloro-1,8-naphthyridin-2-yl)-3-oxo-1-isoindolinyl 3-diisopropylaminopropionate (2.7 g), m.p. 135° C., is obtained.
後処理
- customafter the residue obtained
- customhas been recrystallized successively, first in acetonitrile
出典と根拠
- ORDレコード
- ord-17f601b883ca47918467e3dd1059813b
- 出典データセット
- uspto-grants-1992_04
- 特許番号
- US05102890
反応ノート
読み込み中…